Immunohistochemical expression of MMP-7 protein and its serum level in colorectal cancer

Folia Histochemica et Cytobiologica

Volumn 51, Issue 3, 2013, Pages 206-212

  Pryczynicz, Anna ^a   Gryko, Mariusz ^a   Niewiarowska, Katarzyna ^a   Dymicka Piekarska, Violetta ^a   Ustymowicz, Marek ^b   Hawryluk, Maciej ^a   Cepowicz, Dariusz ^a   Borsuk, Agnieszka ^a   Kemona, Andrzej ^a   Famulski, Waldemar ^a   Guzinska Ustymowicz, Katarzyna ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b BIALYSTOK UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Colon; Colorectal cancer; Matrix metalloproteinase 7; Metastasis; Rectum; Serum level

Indexed keywords

MATRILYSIN; TUMOR MARKER;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER STAGING; CANCER TISSUE; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DISTANT METASTASIS; ENZYME ANALYSIS; ENZYME BLOOD LEVEL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE MUCOSA; MALE; PREOPERATIVE PERIOD; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEIVER OPERATING CHARACTERISTIC; RECTUM; SENSITIVITY AND SPECIFICITY; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MALE; MATRIX METALLOPROTEINASE 7; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL;

EID: 84887325017     PISSN: 02398508     EISSN: 18975631     Source Type: Journal    
DOI: 10.5603/FHC.2013.0029     Document Type: Article

References (37)

1. World Health Organization Cancer Incidence in Five Continents. Lyon. The World Health Organization and The International Agency for Research on Cancer. 2002.
2. Boyle P, Langman JS. ABC of colorectal cancer: Epidemiology. BMJ. 2000;321:805-808.
3. Boyle P, Ferlay J. Mortality and survival in breast and colorectal cancer. Nat Clin Pract Oncol. 2005;2:424-425.
4. Jemal A, Clegg L X, Ward E et al. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer. 2004;101:3-27.
5. Hua H, Li M, Luo T et al. Matrix metalloproteinases in tumorigenesis: an evolving paradigm. Cell Mol Life Sci. 2011;68:3853-3868.
6. Friedl P, Wolf K. Tube travel: the role of proteases in individual and collective cancer cell invasion. Cancer Res. 2008;68:7247-7249.
7. Gaire M, Magbanua Z, McDonnell S et al. Structure and expression of the human gene for the matrix metalloproteinase matrilysin. J Biol Chem. 1994;269:2032-2040.
8. Harrell PC, McCawley LJ, Fingleton B et al. Proliferative effects of apical, but not basal, matrix metalloproteinase-7 activi ty in polarized MDCK cells. Exp Cell Res. 2005;303:308-320.
9. Woessner JF Jr, Taplin CJ. Purification and properties of a small latent matrix metalloproteinase of the rat uterus. J Biol Chem. 1988;263:16918-16925.
10. Wilson CL, Matrisian LM. Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions. Int J Biochem Cell Biol. 1996;28:123-136.
11. McDonnell S, Navre M, Coffey RJ Jr et al. Expression and localization of the matrix metalloproteinase pump-1 (MMP- 7) in human gastric and colon carcinomas. Mol Carcinog. 1991;4:527-533.
12. Stenvold H, Donnem T, Andersen S et al. Overexpression of matrix metalloproteinase-7 and -9 in NSCLC tumor and stromal cells: correlation with a favorable clinical outcome. Lung Cancer. 2012;75:235-241.
13. Zhou JH, Zhang B, Kernstine KH et al. Autoantibodies against MMP-7 as a novel diagnostic biomarker in esophageal squamous cell carcinoma. World J Gastroenterol. 2011;17:1373-1378.
14. Koskensalo S, Mrena J, Wiksten JP et al. MMP-7 overexpression is an independent prognostic marker in gastric cancer. Tumour Biol. 2010;31:149-155.
15. Masaki T, Matsuoka H, Sugiyama M et al. Matrilysin (MMP- 7) as a significant determinant of malignant potential of early invasive colorectal carcinomas. Br J Cancer. 2001;84:1317-1321.
16. Noë V, Fingleton B, Jacobs K et al. Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin- 1. J Cell Sci. 2001;114:111-118.
17. Lynch CC, Hikosaka A, Acuff HB et al. MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL. Cancer Cell. 2005;7:485-496.
18. von Bredow DC, Nagle RB, Bowden GT et al. Cleavage of beta 4 integrin by matrilysin. Exp Cell Res. 1997;236:341-345.
19. Yu WH, Woessner JF Jr, McNeish JD et al. CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. Genes Dev. 2002;16:307-323.
20. Miyamoto S, Yano K, Sugimoto S et al. Matrix metalloproteinase- 7 facilitates insulin-like growth factor bioavailability through its proteinase activity on insulin-like growth factor binding protein 3. Cancer Res. 2004;64:665-671.
21. Hemers E, Duval C, McCaig C et al. Insulin-like growth factor binding protein-5 is a target of matrix metalloproteinase-7: implications for epithelial-mesenchymal signaling. Cancer Res. 2005;65:7363-7369.
22. Davies G, Jiang WG, Mason MD. Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: a key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasion. Clin Cancer Res. 2001;7:3289-3297.
23. Mitsiades N, Yu WH, Poulaki V et al. Matrix metalloproteinase- 7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity. Cancer Res. 2001;61:577-581.
24. Lin HC, Chang JH, Jain S et al. Matrilysin cleavage of corneal collagen type XVIII NC1 domain and generation of a 28-kDa fragment. Invest Ophthalmol Vis Sci. 2001;42:2517-2524.
25. Li Q, Park PW, Wilson CL et al. Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell. 2002;111:635-646.
26. Gomes EG, Jucá MJ, de Menezes HL et al. Correlation between the immunohistochemical expressions of MMP- 1, MMP-7 and VEGF and prognostic factors in colorectal adenocarcinoma. Acta Cir Bras. 2009;24:303-310.
27. Luo HZ, Xia XQ, Zhou ZG et al. Expression and clinical significance of matrilysin (MMP-7) in human rectal cancer. Sichuan Da Xue Xue Bao Yi Xue Ban. 2007;38:637-640.
28. Koskensalo S, Louhimo J, Nordling S et al. MMP-7 as a prognostic marker in colorectal cancer. Tumour Biol. 2011;32:259-264.
29. Masaki T, Sugiyama M, Matsuoka H et al. Matrix metalloproteinases may contribute compensationally to tumor invasion in T1 colorectal carcinomas. Anticancer Res. 2003;23:4169-4173.
30. Adachi Y, Yamamoto H, Itoh F et al. Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers. Gut. 1999;45:252-258.
31. Mori M, Barnard GF, Mimori K et al. Overexpression of matrix metalloproteinase-7 mRNA in human colon carcinomas. Cancer. 1995;75:1516-1519.
32. Pesta M, Holubec L Jr, Topolcan O et al. Quantitative estimation of matrix metalloproteinases 2 and 7 (MMP-2, MMP-7) and tissue inhibitors of matrix metalloproteinases 1 and 2 (TIMP-1, TIMP-2) in colorectal carcinoma tissue samples. Anticancer Res. 2005;25:3387-3391.
33. Wang WS, Chen PM, Wang HS et al. Matrix metalloproteinase- 7 increases resistance to Fas-mediated apoptosis and is a poor prognostic factor of patients with colorectal carcinoma. Carcinogenesis. 2006;27:1113-1120.
34. Ogawa M, Ikeuchi K, Watanabe M et al. Expression of matrix metalloproteinase 7, laminin and type IV collagen- associated liver metastasis in human colorectal cancer: immunohistochemical approach. Hepatogastroenterology. 2005;52:875-880.
35. Wan Y, Wei Q, Pan Y et al. Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal neoplasm. Zhonghua Wai Ke Za Zhi. 2000;38:510-513.
36. Maurel J, Nadal C, Garcia-Albeniz X et al. Serum matrix metalloproteinase 7 levels identifies poor prognosis advanced colorectal cancer patients. Int J Cancer. 2007;121:1066-1071.
37. Martínez-Fernandez A, García-Albeniz X, Pineda E et al. Serum matrilysin levels predict outcome in curatively resected colorectal cancer patients. Ann Surg Oncol. 2009;16:1412-1420.